Skip to main content
. 2023 Jun 7;14:1185799. doi: 10.3389/fendo.2023.1185799

Figure 5.

Figure 5

The prognostic value of KLRB1 in breast cancer. (A, B) Univariate and multivariate Cox regression analysis. (C) Nomogram predicting the probability of 1-year, 3-year, and 5-year OS for risk score and clinical characteristics. (D) Calibration curves of the nomogram for predicting of 1-, 3-, and 5-year OS in all BC patients. GO and KEGG enrichment analysis of KLRB1 associated genes. OS, overall survival. (E) The genome showing high expression of KLRB1 exhibited notable enrichment in immune-related activities. (F) The KLRB1 low expression genome was mainly enriched in metabolic and biosynthetic pathways.